FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Tesla's Cybertruck faces another recall, highlighting ongoing quality issues that challenge the vehicle's market acceptance.
Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Tesla's Cybertruck faces another recall, highlighting ongoing quality issues that challenge the vehicle's market acceptance.
Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity